{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:40:33Z","timestamp":1792222833936,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.taap.2026.118084","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:13:08Z","timestamp":1792077188000},"page":"118084","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Luteolin as a potential intervention for bleomycin-induced pulmonary fibrosis: targeting the AKT\/mTOR\/HIF-1\u03b1\/MMP2 axis"],"prefix":"10.1016","volume":"517","author":[{"given":"Chenhao","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2026.118084_bb0005","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/1097-0142(197304)31:4<903::AID-CNCR2820310422>3.0.CO;2-N","article-title":"A clinical review of bleomycin--a new antineoplastic agent","volume":"31","author":"Blum","year":"1973","journal-title":"Cancer"},{"key":"10.1016\/j.taap.2026.118084_bb0010","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/s41590-024-01934-6","article-title":"Tracing the origins of lung fibrosis","volume":"25","author":"Buckley","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.taap.2026.118084_bb0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.freeradbiomed.2017.10.370","article-title":"P23 - mitochondrial dynamics in lung fibrosis","volume":"112","author":"Carter","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2026.118084_bb0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0272-5231(21)00669-9","article-title":"Possible mechanisms of bleomycin-induced fibrosis","volume":"11","author":"Chandler","year":"1990","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.taap.2026.118084_bb0025","doi-asserted-by":"crossref","first-page":"11653","DOI":"10.1021\/jf1031668","article-title":"Luteolin ameliorates experimental lung fibrosis both in vivo and in vitro: implications for therapy of lung fibrosis","volume":"58","author":"Chen","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.taap.2026.118084_bb0030","doi-asserted-by":"crossref","first-page":"5811","DOI":"10.1038\/s41388-018-0382-1","article-title":"Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription","volume":"37","author":"Deng","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.taap.2026.118084_bb0035","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.critrevonc.2012.12.003","article-title":"Revisiting bleomycin from pathophysiology to safe clinical use","volume":"87","author":"Froudarakis","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.taap.2026.118084_bb0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.yjmcc.2016.01.016","article-title":"Polymerase delta-interacting protein 2 regulates collagen accumulation via activation of the Akt\/mTOR pathway in vascular smooth muscle cells","volume":"92","author":"Fujii","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.taap.2026.118084_bb0045","article-title":"2,3,5,4\u2032-tetrahydroxystilbene-2-O-\u03b2-D-glucoside ameliorates bleomycin-induced pulmonary fibrosis via regulating pro-fibrotic signaling pathways","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2026.118084_bb0055","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.rmed.2015.02.002","article-title":"Natural history of idiopathic pulmonary fibrosis","volume":"109","author":"Kim","year":"2015","journal-title":"Respir. Med."},{"key":"10.1016\/j.taap.2026.118084_bb0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5487\/TR.2010.26.3.217","article-title":"Dose-response effects of bleomycin on inflammation and pulmonary fibrosis in mice","volume":"26","author":"Kim","year":"2010","journal-title":"Toxicol. Res."},{"issue":"Suppl","key":"10.1016\/j.taap.2026.118084_bb0060","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.alit.2016.06.010","article-title":"Epithelial-mesenchymal transition promotes reactivity of human lung adenocarcinoma A549 cells to CpG ODN","volume":"65","author":"Kobayashi","year":"2016","journal-title":"Allergol. Int."},{"key":"10.1016\/j.taap.2026.118084_bb0065","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.molmed.2023.08.010","article-title":"Pulmonary fibrosis: from pathogenesis to clinical decision-making","volume":"29","author":"Koudstaal","year":"2023","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.taap.2026.118084_bb0070","article-title":"Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials","volume":"3","author":"Lancaster","year":"2016","journal-title":"BMJ Open Respir. Res."},{"key":"10.1016\/j.taap.2026.118084_bb0075","doi-asserted-by":"crossref","first-page":"T105","DOI":"10.1111\/j.1750-3841.2010.01702.x","article-title":"Toxicity study of ethanolic extract of Chrysanthemum morifolium in rats","volume":"75","author":"Li","year":"2010","journal-title":"J. Food Sci."},{"key":"10.1016\/j.taap.2026.118084_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116282","article-title":"Selpercatinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-\u03b21 signaling pathway","volume":"225","author":"Li","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2026.118084_bb0080","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3389\/fphar.2019.01021","article-title":"Antifibrotic mechanism of Cinobufagin in bleomycin-induced pulmonary fibrosis in mice","volume":"10","author":"Li","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2026.118084_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2022.103492","article-title":"Inhalation of tetrandrine liposomes for the treatment of bleomycin induced idiopathic pulmonary fibrosis","volume":"74","author":"Liang","year":"2022","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.taap.2026.118084_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.806312","article-title":"Gypenosides attenuate pulmonary fibrosis by inhibiting the AKT\/mTOR\/c-Myc pathway","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2026.118084_bb0100","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11655-019-3064-0","article-title":"Network pharmacology in research of Chinese medicine formula: methodology, application and prospective","volume":"26","author":"Luo","year":"2020","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.taap.2026.118084_bb0105","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.matbio.2018.03.001","article-title":"The impaired proteases and anti-proteases balance in idiopathic pulmonary fibrosis","volume":"68-69","author":"Menou","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.taap.2026.118084_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.703084","article-title":"Hypoxia-inducible factor (HIF) in ischemic stroke and neurodegenerative disease","volume":"9","author":"Mitroshina","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.taap.2026.118084_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2025.117596","article-title":"Apremilast attenuates methotrexate-induced hepatic injury in rats; insights into TLR4\/NF-\u03baB\/P38 MAPK\/caspase-3 and \u03b1-klotho\/Nrf2\/HO-1 signaling network interplay","volume":"505","author":"Mohyeldin","year":"2025","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2026.118084_bb0120","doi-asserted-by":"crossref","first-page":"15609","DOI":"10.1007\/s00210-026-05345-2","article-title":"Atomoxetine attenuates methotrexate-induced lung injury in rats implicating TLR4\/NF-\u03baB and Bax\/Bcl-2\/caspase-3 signaling cascades: a study based on molecular docking and experimental validation","volume":"399","author":"Mohyeldin","year":"2026","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"issue":"7","key":"10.1016\/j.taap.2026.118084_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202400980","article-title":"Luteolin-loaded hyaluronidase nanoparticles with deep tissue penetration capability for idiopathic pulmonary fibrosis treatment","volume":"9","author":"Pan","year":"2024","journal-title":"Small Methods"},{"key":"10.1016\/j.taap.2026.118084_bb0130","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.taap.2026.118084_bb0135","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.taap.2026.118084_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123405","article-title":"Cyclodextrin MOFs modified dry powder inhalers quadruple bioavailability of luteolin to ameliorate fibrosing interstitial lung disease","volume":"645","author":"Ren","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.taap.2026.118084_bb0145","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","article-title":"Idiopathic pulmonary fibrosis","volume":"389","author":"Richeldi","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2026.118084_bb0150","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1378\/chest.63.4.626","article-title":"Bleomycin pulmonary toxicity","volume":"63","author":"Rudders","year":"1973","journal-title":"Chest"},{"key":"10.1016\/j.taap.2026.118084_bb0155","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.taap.2026.118084_bb0160","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-026-05688-w","article-title":"Current perspectives on natural and pharmacological interventions for combating drug-induced pulmonary toxicity","author":"Sharata","year":"2026","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.taap.2026.118084_bb0165","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/MCP.0b013e328363f4de","article-title":"Extracellular matrix microenvironment contributes actively to pulmonary fibrosis","volume":"19","author":"Shimbori","year":"2013","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.taap.2026.118084_bb0170","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.devcel.2022.02.024","article-title":"The central moTOR of metabolism","volume":"57","author":"Simcox","year":"2022","journal-title":"Dev. Cell"},{"key":"10.1016\/j.taap.2026.118084_bb0175","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jinorgbio.2017.11.010","article-title":"Dietary luteolin protects against HgCl2-induced renal injury via activation of Nrf2-mediated signaling in rat","volume":"179","author":"Tan","year":"2018","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.taap.2026.118084_bb0180","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3892\/ijo.2015.3056","article-title":"Overexpression of hypoxia-inducible factor 1\u03b1 induces migration and invasion through notch signaling","volume":"47","author":"Tian","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.taap.2026.118084_bb0190","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/1097-0142(1967)20:5<891::AID-CNCR2820200550>3.0.CO;2-V","article-title":"Studies on bleomycin","volume":"20","author":"Umezawa","year":"1967","journal-title":"Cancer"},{"key":"10.1016\/j.taap.2026.118084_bb0185","first-page":"200","article-title":"New antibiotics, bleomycin A and B","volume":"19","author":"Umezawa","year":"1966","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.taap.2026.118084_bb0195","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.apsb.2021.07.023","article-title":"Targeting PI3K\/AKT signaling for treatment of idiopathic pulmonary fibrosis","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.taap.2026.118084_bb0200","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(22)01052-2","article-title":"Interstitial lung diseases","volume":"400","author":"Wijsenbeek","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2026.118084_bb0205","doi-asserted-by":"crossref","first-page":"861","DOI":"10.7326\/0003-4819-77-6-861","article-title":"Bleomycin, an antitumor antibiotic. Clinical experience in 274 patients","volume":"77","author":"Yagoda","year":"1972","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.taap.2026.118084_bb0210","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2021.4965","article-title":"TGF-\u03b21: gentlemanly orchestrator in idiopathic pulmonary fibrosis (review)","volume":"48","author":"Ye","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.taap.2026.118084_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2020.127762","article-title":"Hydroxyproline determination for initial detection of halal-critical food ingredients (gelatin and collagen)","volume":"337","author":"Yuswan","year":"2021","journal-title":"Food Chem."},{"key":"10.1016\/j.taap.2026.118084_bb0220","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.biopha.2017.05.033","article-title":"The protective effect of Luteolin on myocardial ischemia\/reperfusion (I\/R) injury through TLR4\/NF-\u03baB\/NLRP3 inflammasome pathway","volume":"91","author":"Zhang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.taap.2026.118084_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113862","article-title":"M2 macrophage-targeted metal-polyphenol networks (MPNs) for OPN siRNA delivery and idiopathic pulmonary fibrosis therapy","volume":"383","author":"Zheng","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.taap.2026.118084_bb0230","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1002\/ptr.8217","article-title":"Luteolin: a promising multifunctional natural flavonoid for human diseases","volume":"38","author":"Zhu","year":"2024","journal-title":"Phytother. Res."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26003807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26003807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:53:46Z","timestamp":1792220026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X26003807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":46,"alternative-id":["S0041008X26003807"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2026.118084","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Luteolin as a potential intervention for bleomycin-induced pulmonary fibrosis: targeting the AKT\/mTOR\/HIF-1\u03b1\/MMP2 axis","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2026.118084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118084"}}